# Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul Nathan,Jessica C. Hassel,Piotr Rutkowski,Jean‐François Baurain,Marcus O. Butler,Max Schlaak,Ryan J. Sullivan,Sebastian Ochsenreither,Reinhard Dummer,John M. Kirkwood,Anthony M. Joshua,Joseph J. Sacco,Alexander N. Shoushtari,Marlana Orloff,Josep M. Piulats,Mohammed Milhem,April K.S. Salama,Brendan D. Curti,Lev Demidov,Lauris Gastaud,Cornelia Mauch,Melinda Yushak,Richard D. Carvajal,Omid Hamid,Shaad E. Abdullah,Chris Holland,Howard Goodall,Sophie Piperno‐Neumann |
| Citations | 897 |
| DOI | 10.1056/nejmoa2103485 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa2103485?articleTools=true |
| OpenAlex ID | https://openalex.org/W3200574709 |
| PMID | 34551229 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jean‐François Baurain](https://scholariq.org/researchers/jean-francois-baurain/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Ocular Oncology and Treatments](https://scholariq.org/topics/ocular-oncology-and-treatments/)

## Paper topics

- [Ocular Oncology and Treatments](https://scholariq.org/topics/ocular-oncology-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Veterinary Oncology Research](https://scholariq.org/topics/veterinary-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.